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Profiling Identifies Functionally Distinct
Human Dermal Fibroblast Subpopulations
Christina Philippeos1, Stephanie B. Telerman1, Be´ne´dicte Oule`s1, Angela O. Pisco1,
Tanya J. Shaw2, Raul Elgueta3, Giovanna Lombardi3, Ryan R. Driskell1,4, Mark Soldin5,
Magnus D. Lynch1,6,7 and Fiona M. Watt1,7Previous studies have shown that mouse dermis is composed of functionally distinct fibroblast lineages. To
explore the extent of fibroblast heterogeneity in human skin, we used a combination of comparative spatial
transcriptional profiling of human and mouse dermis and single-cell transcriptional profiling of human dermal
fibroblasts. We show that there are at least four distinct fibroblast populations in adult human skin, not all of
which are spatially segregated. We define markers permitting their isolation and show that although marker
expression is lost in culture, different fibroblast subpopulations retain distinct functionality in terms of Wnt
signaling, responsiveness to IFN-g, and ability to support human epidermal reconstitution when introduced
into decellularized dermis. These findings suggest that ex vivo expansion or in vivo ablation of specific
fibroblast subpopulations may have therapeutic applications in wound healing and diseases characterized by
excessive fibrosis.
Journal of Investigative Dermatology (2018) 138, 811e825; doi:10.1016/j.jid.2018.01.016INTRODUCTION
Although cell lineage relationships within the epidermis have
been studied in detail (Kretzschmar and Watt, 2012), the
functional identity of fibroblasts in the dermis is less well
characterized (Driskell and Watt, 2015). Fibroblasts are cells
that synthesize and integrate structural proteins such as
collagen and elastin into the extracellular matrix of most
mesenchymal tissues (Kalluri and Zeisberg, 2006; Parsonage
et al., 2005; Tomasek et al., 2002; Watt and Fujiwara, 2011).
The dermis has distinct layers that are readily identified his-
tologically: the papillary dermis lies closest to the epidermis,
whereas the underlying reticular dermis is thicker and contains
the bulk of the fibrillar extracellular matrix (Harper andGrove,
1979). Beneath the reticular dermis lies the hypodermis, or
dermal white adipose tissue (Driskell et al., 2014; Festa et al.,1King’s College London Centre for Stem Cells and Regenerative Medicine,
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tified in mouse and human dermis include the dermal papilla
cells at the base of the hair follicle (Lee and Tumbar, 2012;
Sennett and Rendl, 2012), the cells of the arrector pili mus-
cle, and pericytes that are in close association with blood
vessels (Paquet-Fifield et al., 2009).
It has long been suspected that papillary and reticular fi-
broblasts have distinct identities (Harper and Grove, 1979). In
the case of mouse dermis, we and others have shown, via
lineage tracing under homeostatic conditions, during wound
healing and in skin reconstitution assays, that the papillary and
reticular fibroblasts represent functionally distinct lineages that
arise from a multipotent progenitor population during em-
bryonic development (Driskell et al., 2013; Rinkevich et al.,
2015). In mouse models, papillary fibroblasts are required
for new hair follicle formation in the wound bed and in skin
reconstitution assays. In contrast, reticular fibroblasts are the
first to enter a wound and express the so-called fibroblast
activation marker a-smooth muscle actin.
The presence of functionally distinct fibroblast sub-
populations within human dermis is potentially of great in-
terest. In addition to the response to wounding, they may play
different roles in inflammatory diseases, fibrosis, and skin
aging and may offer targetable pathways for the modulation
of these pathological states. Previous studies of the human
dermis have mechanically separated papillary from reticular
dermis with a dermatome. Analysis of explant cultures
derived from these separated regions has shown differences
in fibroblast behavior in culture and in gene expression
(Janson et al., 2012; Lee and Cho, 2005; Sorrell et al., 2004).
However, the markers that have been used to distinguish
fibroblasts cultured separately from the papillary and retic-
ular dermis (Janson et al., 2012) have not allowed isolation of
fibroblast subpopulations directly from the skin.estigative Dermatology. This is an open access
www.jidonline.org 811
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812Here, using a combination of transcriptional profiling of
flow-sorted mouse fibroblast subpopulations, spatial profiling
of microdissected human dermis, and single-cell RNA
sequencing of primary human dermal fibroblasts, we define
markers that permit the prospective isolation of human
dermal fibroblast subpopulations and show that prospectively
isolated fibroblasts from the upper and lower dermis exhibit
distinct properties in culture.
RESULTS
Differential expression of genes associated with Wnt,
extracellular matrix (ECM), and immune signaling in
neonatal mouse fibroblast subpopulations
GFPþ fibroblasts isolated from the back skin of PdgfraH2-
BeGFP reporter mice at postnatal day 2 can be separated by
flow cytometry on the basis of expression of cell surface
markers CD26, Sca1, and Dlk1 (Driskell et al., 2013). To
identify additional markers and signaling pathways that
distinguish these cell populations, we performed tran-
scriptomic analysis of flow-sorted postnatal day 2 GFPþ fi-
broblasts (see Supplementary Figure S1 online). Reticular
fibroblasts were isolated by gating for Dlk1þSca1e cells. Two
separate pre-adipocyte populations are positive for Sca1 and
can be distinguished from one another using
Dlk1:Dlk1þSca1þ cells and Dlk1eSca1þ cells. Papillary cells
were isolated as CD26þSca1e. RNA was extracted and sub-
jected to Affymetrix (Santa Clara, CA) microarray analysis and
quantitative PCR validation of CD26, Sca1, and Dlk1
expression (see Supplementary Figure S1bee; see Materials
and Methods sections for data access via Gene Expression
Omnibus). Marker expression was confirmed in mRNA iso-
lated from flow-sorted populations (see Supplementary
Figure S1c) and in the microarrays (see Supplementary
Figure S1d).
Principal component analysis was used to assess the re-
lationships between the different cell populations (see
Supplementary Figure S1b). The samples aligned along the
PC1 (y) axis according to their differentiated state. The two
Sca1þ (pre-adipocyte) populations were located closest
together in PC1. One of the Dlk1eSca1þ samples clustered
with the Dlk1þSca1þ samples and had higher levels of Dlk1
than the other Dlk1eSca1þ samples in the microarray, most
likely reflecting a technical failure during flow sorting. This
sample was therefore excluded from subsequent analysis.
Hierarchical clustering of gene expression levels confirmed
that the same cell populations from different mice clustered
together (see Supplementary Figure S1e).
Gene ontology term analysis of differentially expressed
genes (see Figure 1a) confirmed up-regulation of the Wnt
signaling pathway in the papillary fibroblasts (Driskell et al.,
2013; Rognoni et al., 2016). The top gene ontology term for
reticular fibroblasts was ECM organization, whereas the
Dlk1eSca1þ top gene ontology terms related to muscle,
which might reflect the presence of fibro-/adipogenic pro-
genitors in the underlying panniculus carnosus muscle
(Natarajan et al., 2010). The top pathways in Dlk1þSca1þ
cells related to chemotaxis and inflammation.
Heat maps of differentially expressed Wnt, ECM, and
inflammation-associated genes are shown in Figure 1bed.
Differential expression of several genes was confirmed byJournal of Investigative Dermatology (2018), Volume 138qPCR: Wnt pathway genes Tcf4, Lef1, and Axin 2 were more
highly expressed in CD26þSca1e papillary fibroblasts than in
the other populations, whereas Cxcl1 and Cxcl12 were
significantly down-regulated in papillary fibroblasts
(Figure 1e). Dlk1þSca1þ cells expressed higher levels of
genes encoding fibrillar ECM proteins, such as fibrillin
(FBN1), than Dlk1eSca1þ cells (Figure 1d).
Sca1þ mouse dermal fibroblasts can differentiate into ad-
ipocytes in vivo and in culture (Driskell et al., 2013;
Mastrogiannaki et al., 2016); however, Dlk1þSca1e fibro-
blasts also have adipogenic activity (Driskell et al., 2013). To
gain insights into the nature of the two pre-adipocyte pop-
ulations, we compared expression of a panel of adipogenic
markers (Figure 1f). Both Dlk1þSca1þ and Dlk1eSca1þ
populations expressed higher levels of known pre-adipocyte
markers (Rivera-Gonzalez et al., 2016), such as Pparg and
Fabp4, than the other populations (Figure 1f). However,
reticular fibroblasts (Dlk1þSca1e) had the highest levels of
the pre-adipocyte marker CD24 (Festa et al., 2011)
(Figure 1f). Both Sca1þ populations expressed higher levels of
the fatty acid transporter CD36 (Kuniyasu et al., 2003) than
the other fibroblast subpopulations (Figure 1g), and CD39
was up-regulated in CD26þSca1e cells (Figure 1h).
Spatial transcriptional profiling of human dermis
To test whether spatial differences in gene expression are
conserved between mouse and human, we enzymatically
removed the epidermis from human skin samples (three adult
female breast skin samples from separate individuals) and
then microdissected papillary from reticular dermis under a
dissecting microscope. RNA was extracted separately from
the upper 100 mm (papillary) and 200e500 mm (reticular)
human dermal layers and subjected to amplification and
RNA sequencing. Hierarchical clustering of gene expression
showed that cells in papillary and reticular dermis had
distinct gene expression profiles and that samples from the
same spatial location derived from different individuals co-
associated (Figure 2a).
To identify pan-fibroblast markers (Kalluri and Zeisberg,
2006), we compared our gene expression profiles with pub-
lished RNA sequencing data from six cultured human fibro-
blast lines and seven non-fibroblast cell lines (see
Supplementary Figure S2a and b online). Pan-fibroblast
markers were defined as genes expressed at a high level in
both layers of the dermis and all cultured fibroblast lines but
not detectable in other cultured cell types. The only cell
surface markers meeting these criteria were the known
markers CD90 (Saalbach et al., 1998) (although CD90 is also
expressed in human embryonic stem cells), PDGFRa, and
PDGFRb (Driskell and Watt, 2015) (see Supplementary
Figure S2b). However, the analysis did identify the small
leucine-rich proteoglycans LUM and DCN as secreted pan-
fibroblast markers (see Supplementary Figure S2a).
Next, we analyzed the genes that were differentially
expressed in the different layers of human dermis to find
markers for papillary and reticular fibroblasts (Figure 2b and
c). One of the most highly enriched markers in papillary
dermis was the a5 chain of collagen VI (COL6A5) (Fitzgerald
et al., 2008, 2013; Gara et al., 2008). COL23A1 was also
overexpressed in the papillary versus reticular dermis. There
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Figure 1. Differential expression of genes associated with Wnt, ECM, and immune signaling in mouse fibroblast subpopulations. (a) Gene Ontology
term analysis of differentially expressed pathways in mouse fibroblast subpopulations. (bed) Heat maps illustrating differential expression (Affymetrix microarray)
of genes implicated in (b) Wnt signaling, (c) inflammation, and (d) ECM regulation. (e) qPCR validation of selected differentially expressed genes.
(f) Heatmap comparing expression (Affymetrix microarray) of genes implicated in adipogenesis. (g, h) qPCR analysis showing up-regulation of CD36 expression in
(g) pre-adipocyte populations and (h) CD39 in papillary fibroblasts. (e, g, h) Gene expression is normalized to GAPDH and expressed as mean standard deviation
for three biological replicates. *P < 0.05, **P < 0.005, ***P < 0.0005. EC, extracellular; ECM, extracellular matrix; qPCR, quantitative PCR.
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Figure 2. Spatial profiling of gene expression in human dermis. (a) Hierarchical clustering of gene expression patterns from papillary and reticular dermis in
three separate individuals (breast skin samples derived from three donors). Expression was quantified by RNA sequencing (blue, similar; red, dissimilar).
(b) Genes up-regulated in papillary dermis (>3-fold). (c) Genes up-regulated in reticular dermis (>10-fold). (d) Cell surface markers for which expression was at
least 2-fold up-regulated in papillary dermis. Expression level is indicated separately for each of the three biological replicates (green, high; red, low)
and compared with expression in six different cultured fibroblast lines and seven other cultured cell lines. (e) Cell surface markers at least 2-fold up-regulated
in reticular dermis. (f) Cell surface markers up-regulated in papillary dermis that are conserved between human adult dermis and mouse P2 dermis.
P2, postnatal day 2.
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814was also increased expression of components of the Wnt
pathway (WIF1, APCDD1, RSP01, AXIN2) in papillary
dermis, suggesting evolutionary conservation between mouse
and human (cf. Figure 1b). The lower dermis did not have a
characteristic ECM signature; however, several members of
the secretoglobin superfamily (SCGB2A2, SCGB1D2,
SLC12A2) were highly expressed. Hair follicle-specific genes
(KRTAP11-1, TCHH) were among the most strongly enriched
in the reticular dermis, which is likely due to the lower hair
follicle remaining embedded within the dermis when the
epidermis was removed before RNA isolation. HighJournal of Investigative Dermatology (2018), Volume 138expression of the breast epithelial marker MUCL1 was also a
feature of the lower dermis, indicating residual mammary
epithelial cells within the preparation.
For functional studies, cell surface markers that distin-
guish fibroblast subpopulations are very valuable. We
therefore filtered the list of differentially expressed genes to
identify cell surface markers enriched in papillary
(Figure 2d) and reticular (Figure 2e) human dermis.
Although CD3g, CD3d, and CD3ε were significantly
enriched in papillary dermis, this most likely reflected dif-
ferences in the content of T cells rather than fibroblast
Figure 3. Immunofluorescence
labeling of human dermis
with antibodies to candidate
fibroblast subpopulation markers
identified by spatial transcriptomics.
(a, b) Expression of COL6A5 is
restricted to the papillary dermis
(female breast skin, donor age 22
years). The basal layer of the
epidermis is labeled with anti-K14
(COL6A5, green; K14, red).
(c, d) Expression of APCDD1 is
enriched in the papillary dermis
(APCDD1, green; K14, red; female
back skin, donor age 44 years).
(e, f) Expression of HSPB3 is enriched
in the papillary dermis (HSPB3,
green; K14, red; female breast skin,
donor age 22 years). (g, h) Expression
of WIF1 is enriched in vascular
structures that are more prominent in
the upper dermis (WIF1, green; K14,
red; female abdominal skin, donor age
27 years). (i, j) Expression of CD36
is highly enriched in the lower dermis
(female abdominal skin, donor age 44
years). (k, l) CD39 is enriched in the
papillary dermis (CD39, green;
podoplanin, red; female abdominal
skin, donor age 43 years). Scale
bars ¼ 200 mm. K14, keratin.
C Philippeos et al.
Human Skin Fibroblast Heterogeneitysubpopulations. We also identified cell surface markers that
were differentially expressed in both mouse and human
dermal lineages (Figure 2f). No conserved markers of
reticular lineages were identified; however, CD39 wasidentified as a conserved marker of papillary dermal line-
ages in both mouse and humans.
To validate differential expression of the genes identified by
RNA sequencing, we performed antibody labeling on skinwww.jidonline.org 815
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Human Skin Fibroblast Heterogeneitysections derived from three individuals (breast skin). We
confirmed that COL6A5 expression was restricted to papil-
lary dermal fibroblasts (Figure 3a and b) (Martinelli-Boneschi
et al., 2017; Sabatelli et al., 2011). Immunostaining for
APCDD1 (Figure 3c and d), HSPB3 (Figure 3e and f), and
WIF1 (Figure 3g and h) confirmed differential expression of
these markers in papillary dermis (Figure 2b). Consistent with
their expression in mouse fibroblast subpopulations
(Figure 1g and h), CD36 was up-regulated in the lower
reticular dermis and hypodermis (Figure 3i and j, data not
shown), and CD39 was up-regulated in the papillary dermis
(Figure 3k and l). This is in keeping with the in vitro expres-
sion of CD36 by adipocyte progenitors and mature adipo-
cytes in vitro (Gao et al., 2017).
Functional heterogeneity of flow-sorted human fibroblasts
Based on our analysis of mouse and human fibroblasts, we
flow sorted human fibroblasts that were linage negative (line)
(i.e., CD31eCD45eE-cadherine) CD90þCD39þ (papillary)
or lineCD90þCD36þ (lower reticular/hypodermal) and
compared their properties after expansion in culture for up
to four passages (Figure 4). We confirmed that expression
of LUM and COL6A5 was enriched in unfractionated
CD90þ fibroblasts relative to total dermis (Figure 4a and b).
After a single passage, expressions of CD39 and COL6A5
were completely lost from prospectively isolated CD31e
CD45-eECade cells; however, expression of CD90, LUM,
and CD36 was maintained (Figure 4cee, g). This shows
that culture, rather than competition between different
fibroblast subpopulations, leads to the loss of fibroblast
markers.
Although expression of CD39 and COL6A5 was rapidly
lost, lineCD90þCD39þ and lineCD90þCD36þ populations
exhibited differences in morphology in culture. There was a
tendency toward a more spindle-shaped morphology for
CD39þ cells, with CD36þ cells exhibiting a more epithelioid
shape (Figure 4f). However, there was considerable variation
between donors, with no obvious correlation between age or
donor site (Figure 4f). qPCR showed that genes encoding
several ECM components (Figure 4j) and inflammatory me-
diators (Figure 4i) continued to be more highly expressed in
CD36þ cells. However, the elevated expression of Wnt
pathway genes associated with papillary dermis was lost with
culture (Figure 4h).
To examine the functional significance of differential
expression of inflammatory mediators (Figure 4i), we per-
formed IFNg stimulation assays (Figure 4keo). We observed
clear differences in the response of lineCD90þCD39þ
(upper dermis) compared with lineCD90þCD36þ (lower
dermis/hypodermis), with a significant reduction in theconsiderable intersample variation. Breast skin donor age, 19 years; abdominal
mm). (g) Quantitative PCR showing retention of LUM and loss of COL6A5 in cu
standard deviation for three biological replicates. (hej) Expression of genes ass
remodeling. Gene expression is normalized to 18S and is expressed as mean 
years) abdominal skin, female (age 46 years) thigh skin, and female (age 64 yea
response to IFN-g stimulation in culture (blue, CD39þIFN-g; yellow, CD36þIFN
quantitation of data from three independent experiments derived from female (a
64 years) abdominal skin. *P < 0.05, **P < 0.005, ***P < 0.0005, ****P < 0.00
negative; MFI, mean fluorescence intensity; SSC, side scatter detector.
=upregulation of PDL-1 and CD40 in CD39þ cells. This is
suggestive of an anti-inflammatory phenotype for upper
dermal fibroblasts.
Mouse studies have identified a role for reciprocal Wnt
signaling between basal keratinocytes and upper dermal
fibroblasts in the regulation and maintenance of the
epidermal stem cell compartment (Collins et al., 2011;
Kretzschmar et al., 2016; Lichtenberger et al., 2016;
Rognoni et al., 2016). Although the papillary Wnt gene
signature was lost in culture (Figure 4h), it has been
previously shown that cultured fibroblasts derived from the
papillary dermis support the formation of a normal stratified
epidermis in three-dimensional organotypic culture more
effectively than fibroblasts from the reticular dermis (Janson
et al., 2012; Lee and Cho, 2005; Sorrell et al., 2004).
We therefore assessed the ability of cultured fibroblast
subpopulations to repopulate decellularized human
dermis (DED) and support the formation of an architectur-
ally normal epidermis. Flow-sorted lineCD90þCD39þ,
lineCD90þCD39e, and lineCD90þCD36þ cells (Figure 5a)
were expanded in culture and introduced into the upper
surface of DED. Insufficient numbers of cells could be ob-
tained by cell sorting for introduction into DED without the
expansion step. Subsequently, primary human keratinocytes
were added to the surface of the dermis and cultured at the
air-liquid interface.
After 3 weeks in culture, in the absence of fibroblasts,
the epidermis had fewer viable cell layers than normal
epidermis and lacked the pronounced undulations, rete
ridges, characteristic of the healthy tissue (Figure 5b and g).
The addition of unfractionated fibroblasts (CD90þ) led to
formation of a thicker epidermis with some rete ridges
(Figure 5c and h). lineCD90þCD39þ cells more effectively
supported the formation of a multilayered epithelium
(Figure 5d, i, and l) than lineCD90þCD39e cells (Figure 5e
and j) and lineCD90þCD36þ cells (Figure 5f and k). After
seeding, lineCD90þCD39þ remained largely restricted to
the upper dermis, whereas lineCD90þCD39e and
lineCD90þCD36þ cells extended to mid and deep dermis
(Figure 5m and n), and fibroblast density was highest in
DED samples reconstituted with lineCD90þCD39þ cells
(Figure 5m).
Single-cell transcriptional profiling identifies additional
human dermal fibroblast subpopulations
Although our analysis of fibroblasts in different layers of hu-
man dermis supports the concept that fibroblasts are het-
erogeneous, it is possible that additional subpopulations are
admixed between these two locations. To undertake a more
comprehensive assessment of fibroblast subpopulations, weskin donor age, 43 years; and thigh skin donor age, 46 years. Scale bars ¼ 50
lture. Gene expression normalized to GAPDH and expressed as mean 
ociated with (h) Wnt signaling, (i) inflammation and immunity, and (j) ECM
standard deviation for three biological replicates derived from female (age 42
rs) abdominal skin. (keo) Modulation of expression of cell surface markers in
-g; red, unstained control). Top row: representative flow plots. Bottom row:
ge 42 years) abdominal skin, female (age 46 years) thigh skin, and female (age
01. ECM, extracellular matrix; FSC, forward scatter detector; line, lineage
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Figure 5. Comparison of the ability of different fibroblast subpopulations to support epidermal growth on DED. (a) Isolation of fibroblast subpopulations by
flow cytometry. (bef) Hematoxylin and eosin staining (scale bars ¼ 100 mm) and (gek) immunofluorescence staining (scale bars ¼ 200 mm) of DED
organotypic cultures (b, g) without fibroblasts or (c, h) seeded with unfractionated (lineCD90þ) fibroblasts, (d, i) CD90þCD39þ (enriched in papillary)
fibroblasts, (e, j) CD90þCD39e (depleted of papillary) fibroblasts, and (f, k) CD90þCD36þ (reticular/pre-adipocyte) fibroblasts. Keratin 14 (green)
marks keratinocytes, and vimentin (white) marks mesenchymal cells (fibroblasts). Experiments were repeated for a minimum of two biological replicates (donor
cells derived from female [age 19 years] breast skin and female [age 37 years] breast skin; DED derived from male [age 47 years] abdominal skin, and
representative images are displayed. In the case of the CD90þCD39þ cells, two of three experiments involved additional selection for CD26e cells to further
enrich for the papillary cell population (CD90þCD39þCD26e). (l) Quantification of epidermal thickness, (m) density of fibroblasts within 300 mm of the
epidermis, and (n) relative abundance of fibroblasts at different depths from the epidermis. adipo, adipocyte; DED, decellularized human dermis; FB, fibroblasts;
FSC, forward scatter detector; K14, keratin 14; line, lineage negative; ns, not significant; SSC, side scatter detector.
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human dermis after enzymatic removal of the epidermis
(Figure 6a). For five samples of primary human dermis, 12.2%
(standard deviation [SD] ¼ 6.7%) of cells were CD90þ, 9.4%
(SD ¼ 4.7%) were lineCD90þ, and 39.6% (SD ¼ 16.4%)
were lineCD90e. Thus, fibroblasts constitute a small pro-
portion of dermal cells, most being CD31þ endothelial cells
(8.1%, SD ¼ 5.2%), CD45þ (11.6%, SD ¼ 7.4%) hemopoi-
etic cells and other cell types including sweat glands,
neuronal cells, and keratinocytes from hair follicles.
We performed single-cell RNA sequencing for a total of
184 cells derived from the abdominal skin of a single donor
(female, age 64 years). To enrich for fibroblasts, half of the
cells were flow sorted lineCD90þ cells. However, as we
did not wish to potentially exclude unreported, to our
knowledge, fibroblast subsets that were CD90e, half of the
cells were lineCD90þ/e. t-distributed stochastic neighbor
embedding analysis (Figure 6bed) was performed on
global patterns of gene expression for each individual cell;
this method groups cells with similar gene expression.
Automated clustering of the t-distributed stochastic
neighbor embedding analysis (Figure 6d) identified five
groups of cells, although group 1 (red) contained only five
cells.
To characterize the fibroblast subpopulations, we compu-
tationally identified genes that were significantly overex-
pressed in each group (Figure 6e and f). Vimentin, a
mesenchymal cell marker, was expressed in all groups,
establishing that no epidermal cells were profiled DCN and
LUM—the pan-fibroblast markers we identified by spatial
transcriptomics (Figure 2)—were expressed in all groups with
the exception of group 5. Group 5 also contained no
lineCD90þ cells. COL6A5, COL23A1, and HSPB3, identified
by spatial transcriptional profiling as localized to the papil-
lary dermis (Figure 2b), were highly enriched in group 3,
suggesting that this group represents papillary fibroblasts.
CD74 and HLA-DR4, both components of MHC class II
(Karakikes et al., 2012), and CLDN5, a component of tight
junctions (Findley and Koval, 2009), marked group 5.
Although these cells were vimentinþ and line, the lack of
DCN and LUM and expression of CD74 (macrophage
inhibitory factor receptor) and HLA-DR indicate character-
istics of macrophages/dendritic cells (Brocks et al., 2017;
Karakikes et al., 2012). However, CLDN5, another marker
of group 5 cells, is an endothelial marker (Kluger et al.,
2013). Expression of Pparg (PPARG), and to a lesser extent
CD36, both pre-adipocyte markers, was also enriched in
group 5 (see Supplementary Figure S3 online), suggesting that
pre-adipocytes cluster within group 5, of which they make up
a small fraction. Furthermore, a subpopulation of group 5
cells express TEK (TIE2) and might correspond to TIE2-
expressing monocyte/macrophages (Patel et al., 2013).
Although group 2 was one of the largest cell clusters, there
were few specific markers. One of those, RGS5, is well
characterized as a marker of pericytes (Bondjers et al., 2003),
and antibodies to RGS5 labeled blood vessel-associated
pericytes throughout the dermis (Figure 6j). RGS5-positive
cells were limited to the upper half of group 2, suggesting
that cells in the lower half of group 2 represent an alternative
cellular identity.CD26, MFAP5, and PRG4 were identified as markers of
group 4. This population exhibits a CD39þ cell surface
phenotype. Because they do not express high levels of
COL6A5, these cells likely correspond to dermal reticular
fibroblasts. CD26 was also a marker of group 1 cells,
whereas MFAP5 was expressed by cells in group 2. Antibody
labeling indicated that, in contrast to neonatal mouse dermis
(see Supplementary Figure S1), cells expressing CD26 were
absent from adult papillary human dermis (Figure 6h).
MFAP5 was expressed throughout the dermis (Figure 4i).
By flow sorting papillary cells on the basis that they
were CD39þCD26e (Figure 6k and l), we could enrich
for expression of the papillary markers COL6A5, WNT5A,
RSPO1, and LEF1 (Figure 6mep). The differences in
marker distribution within the dermis were confirmed by
staining and flow cytometry of cells from abdomen, back,
thigh, and arm skin (data not shown). Thus, fibroblast
identity is not restricted by spatial compartmentalization
within the dermis.
DISCUSSION
Our results support the concept (Driskell et al., 2013;
Rinkevich et al., 2015) that fibroblasts represent a family
of related cell types with specialized functions in the syn-
thesis and maintenance of extracellular matrix and the co-
ordination and regulation of neighboring cell types. Through
a combination of spatial and single-cell transcriptional
profiling, we have identified at least four human dermal
fibroblast subpopulations. The first, which has a cell surface
phenotype of lineCD90þCD39þCD26e, is characterized
by the expression of specific collagen chains such as
COL6A5 and is localized to the upper dermis. The second
is lineCD90þCD36þ cells that are situated in the lower
dermis and include pre-adipocytes. The remaining three
groups are located throughout the reticular dermis:
lineCD90þCD39eRGS5þ cells that correspond to pericytes
(Bondjers et al., 2003) and lineCD90þCD39þCD26þ and
lineCD90þCD39eRGS5e cells, which to our knowledge
are as yet uncharacterized fibroblast subpopulations. Our
single cell analysis is in good agreement with recent studies
by Tabib et al. (2018).
In contrast to previous studies of the mouse dermis
(Driskell et al., 2009, 2012; Enshell-Seijffers and Morgan,
2008; Rendl et al., 2005), dermal papilla-associated fibro-
blasts were not prominent in our dataset, likely reflecting
the significantly lower density of hair follicles in human
breast and abdomen skin compared with mouse skin. Many
of the cell surface markers identified in our previous study
of the developing mouse dermis were not conserved in the
human. This is not unexpected, because there is poor
conservation of cell surface markers for hematopoietic stem
cells between humans and mice (Ng et al., 2009). However,
all three studies of dermal fibroblast identity have identified
CD26 as a key lineage marker, although the subpopulations
marked appear to differ. During the early stages of mouse
development, CD26 marks an upper dermal lineage; in the
adult mouse, CD26 expression is present in a large fraction
of the dermis (Rinkevich et al., 2015). Here, we found that
CD26 expression, although present in a large fraction of the
human adult dermis, is excluded from the uppermostwww.jidonline.org 819
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Figure 6. Single-cell RNA sequencing of human adult dermal fibroblasts. (a) Isolation of line cells and lineCD90þ cells from human dermis by flow cytometry.
Single live cells were isolated from a single donor (female age 64 years, abdominal skin) by gating for forward scatter, side scatter, and DAPI-staining. line cells
were isolated by gating for CD31eCD45eECade. (b) PCA analysis of gene expression patterns. (c, d) tSNE analysis of gene expression patterns (red, line; blue,
lineCD90þ). (d) Automated clustering of tSNE analysis identifies five dermal fibroblast subpopulations. (e) Expression patterns of markers differentially expressed
in each of five clusters (red, high expression; yellow, low expression. (f) Violin plots illustrating differential expression of marker genes in each of five dermal
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Human Skin Fibroblast Heterogeneity(papillary) fibroblasts. CD26 is a regulator of the inflam-
matory response (Boonacker and Van Noorden, 2003), and
CD26þ fibroblasts are reported to contribute to skin fibrosis
(Hu and Longaker, 2016).
The specification of fibroblast cellular identity likely re-
flects a combination of extrinsic signals emanating from the
spatial context of the cell and intrinsic mechanisms,
including transcriptional and epigenetic regulatory networks.
Our results support a key role for signaling via the Wnt
pathway in the regulation of dermal fibroblast subpopulation
identity. We have found up-regulation of Wnt signaling in
both upper dermal mouse and human fibroblast lineages.
Wnt signaling is required for normal development of mouse
(Ohtola et al., 2008) and human dermis (Grzeschik et al.,
2007), and studies have shown a central role for Wnt
signaling in hair follicle development and regeneration
(Driskell et al., 2012; Kishimoto et al., 2000; Myung et al.,
2013; Silva-Vargas et al., 2005). Epidermal Wnt signaling is
also implicated in the regulation of the hypodermal adipocyte
layer (Donati et al., 2014; Festa et al., 2011) and is critical
for maintenance of the epidermis (Watt et al., 2006). We
propose that there is a mutually synergistic, Wnt-mediated
crosstalk between papillary dermal fibroblasts and basal
keratinocytes that is responsible for the maintenance of the
cellular identity of the papillary dermal fibroblasts. Loss of
this signaling in culture may explain the rapid loss of papil-
lary cell markers.
In addition to differential expression of Wnt pathway
components, we observed differential expression of ECM and
immunoregulatory genes in subpopulations of mouse and
human fibroblasts on isolation from the dermis. This could
reflect either a pro-inflammatory state or simply that these
subpopulations are primed to respond more readily to injury
or infection. We also observed conservation of cell function
after in vitro expansion of upper and lower dermal fibro-
blasts, as evidenced by differences in collagen chain
expression and ability to support the normal development of
a stratified squamous epithelium in three-dimensionale
reconstituted organotypic cell culture. There were also dif-
ferences in the immunological response to IFNg stimulation
in vitro, and future in vivo investigation of this phenomenon
may be informative. Although differences in fibroblast func-
tion are conserved in culture, at least for early passages, the
expression of key subpopulation markers was rapidly lost.
Previous studies have shown that properties of epidermal
stem cells displayed in culture or in transplantation experi-
ments differ from those exhibited in vivo (Kretzschmar and
Watt, 2012; Watt and Jensen, 2009).
An understanding of the differential contribution of fibro-
blast subpopulations to human disease may offer strategies
for therapy (El-Domyati et al., 2002; Gilchrest, 1996; Gurtnerfibroblast subpopulations. (gej) Immunostaining for candidate fibroblast marker
CD26, female breast skin, donor age 62 years; (i) MFAP5, female breast skin, d
bars ¼ 200 mm. (k) Isolation of lineCD39þCD26e and CD39e dermal fibroblasts
RSP01, and (p) LEF1 in lineCD39þCD26e and CD39e dermal fibroblasts. Gen
standard deviation for three biological replicates: male (age 53 years) thigh skin
0.05, **P < 0.005, ***P < 0.0005, ****P < 0.0001. FSC, forward scatter detecto
SSC, side scatter detector; tSNE, t-distributed stochastic neighbor embedding.
=et al., 2008; Jumper et al., 2015; Lee et al., 2004). In this
context it could be envisaged that the action of deleterious
fibroblast subpopulations could be inhibited, perhaps via
inhibition of signaling pathways specific to these sub-
populations or via monoclonal antibody-mediated ablation.
In mice, experimental depletion of fibroblasts during wound
healing can reduce the degree of fibrosis (Dulauroy et al.,
2012). Alternatively, beneficial subpopulations can poten-
tially be expanded ex vivo. Fibroblast therapies are already
being evaluated to treat poorly healing ulcers (Kirsner et al.,
2012) and epidermolysis bullosa (Wong et al., 2008), and
papillary fibroblasts appear more effective than other fibro-
blasts in the construction of tissue-engineered skin substitutes
(Sorrell et al., 2008).
MATERIALS AND METHODS
Histology
Surplus surgical waste skin was obtained from consenting patients
undergoing plastic surgery. This work was ethically approved by the
National Research Ethics Service (UK) (Human Tissue Authority
Licence No. 12121, Research Ethics Committee No. 14/NS/1073).
For histology, tissue samples were embedded in optimal cutting
temperature compound (Life Technologies, Waltham, MA) and stored
at e80C. Sections of 10e16 mm were cut using a Thermo Cryostar
Nx70 (Thermo Fisher Scientific, Waltham, MA). Sections were fixed
in 4% paraformaldehyde, blocked with a solution of 10% donkey
serum, 0.1% fish skin gelatin, 0.1% Triton X-100, and 0.5% Tween-
20 (all from Sigma-Aldrich, St. Louis, MO) in phosphate buffered
saline (PBS) and labeled with primary antibodies diluted in blocking
buffer overnight at 4C. Sections were washed with PBS and then
labeled with secondary antibodies and DAPI for 1 hour at room
temperature, washed with PBS, and mounted with Fluorescence
Mounting Medium (DAKO, Santa Clara, CA).
Antibodies
The following primary antibodies were used for immunofluores-
cence labeling and flow cytometry: anti-mouse CD26 PerCP-Cy5.5
(eBioscience, San Diego, CA; 45-0261-80), anti-human CD26 PE-
Cy5 (Biolegend, San Diego, CA; 302708), anti-mouse CD133 PE
(eBioscience, 12-1331-80), anti-mouse CD133 APC (eBioscience,
17-1331-81), anti-mouse CD140a APC (eBioscience, 17-1401-81),
anti-mouse Ly-6A/E AF700 (eBioscience, 56-5981-82), anti-mouse
Dlk1 PE (MBL International/Caltag Medsystems, Buckingham, UK;
D187-5), anti-human CD31 PE (eBioscience, 12-0319-41), anti-
human CD31 APC-Cy7 (Biolegend, 303119), anti-human CD36
FITC (eBioscience, 11-0369-41), anti-human CD36 PE (Biolegend,
336206), CD39 (eBioscience, 14-0399-82), anti-human CD39 PE
(eBioscience, 1112-0399-41), anti-human CD39 APC (Biolegend,
328210), anti-human CD45 AF700 (eBioscience, 111256-9459-41),
anti-human CD45 APC-Cy7 (Biolegend, 368516), anti-human CD90
PE (eBioscience, 12-0909-41), anti-human CD90 APC (Biolegend,s in adult human skin: (g) COL6A5, female breast skin, donor age 37 years; (h)
onor age 37 years; and (j) RGS5, female back skin, donor age 29 years. Scale
by flow cytometry. (lep) Expression of (l) CD39, (m) COL6A5, (n) WNT5A, (o)
e expression is normalized to GAPDH and TBP and is expressed as mean 
, female (age 52 years) breast skin, and female (age 62 years) breast skin. *P <
r; K14, keratin 14; line, lineage negative; PCA, principle component analysis;
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822328114), anti-human CD324 PerCP/Cy5.5 (Biolegend, 324113),
anti-human CD86 PE (Biolegend, 305405), anti-human CD40 APC/
Cy7 (Biolegend, 334323), anti-human HLA-DR Pacific Blue (Bio-
legend, 327016), anti-human CD80 Brilliant Violet 605 (Biolegend,
305225), anti-human CD274 (PD-L1, B7-H1) PE-cyanine7 (eBio-
science, 25-5983-41), K14 (Cambridge Bioscience, Cambridge, UK;
906001), PDGFR-a (R&D Systems, Minneapolis, MN; AF307-NA),
vimentin (Cell Signaling, Danvers, MA; 5741S), podoplanin (R&D
Systems, AF3244), Col6A5 (Abcam, Cambridge, UK; Ab122836),
APCDD1 (Abcam, Ab171851), HSPB3 (Abcam, Ab150844), WIF-1
(R&D Systems, MAB134), MFAP5 (Atlas Antibodies HPA010553),
and PRG4 (Atlas Antibodies, Bromma, Sweden; HPA028523).
The following secondary antibodies were used: anti-mouse AF555
(Invitrogen, Waltham, MA; A31570), anti-mouse AF647 (Invitrogen,
A31571), anti-goat AF488 (Invitrogen, A110550), anti-goat AF555
(Invitrogen, A21432), anti-rabbit AF488 (Invitrogen, A21206), anti-
rabbit AF555 (Invitrogen, A31572), anti-rat AF488 (Invitrogen,
A21208), anti-rat AF555 (Invitrogen, A21434), and anti-chicken
AF488 (Invitrogen, A11039).
Microscopy
Photomicrographs were taken using a Leica DM IL LED Tissue cul-
ture microscope (Wetzlar, Germany). Confocal microscopy was
performed with a Nikon A1 Upright Confocal microscope (Tokyo,
Japan) using 10 or 20 objectives. Imaging of hematoxylin and
eosin-stained sections was performed using a Hamamatsu Nano-
Zoomer slide scanner (Hamamatsu City, Japan). Image processing
was performed with Nikon Elements, Image J (Fiji) (National In-
stitutes of Health, Bethesda, MD, Photoshop CS6 (Adobe, San Jose,
CA), and Icy software (Quantitative Image Analysis Unit, Institut
Pasteur, Paris, France).
Isolation of neonatal mouse fibroblasts
Postnatal day 2 dermis was harvested as described previously (Jensen
et al., 2010). The mouse limbs, tail, and head were removed. An
anterior-to-posterior incision in the ventral skin was made, and the
skin was separated from the carcass. Skin was incubated for 1 hour
at 37C in a solution of trypsin/EDTA (Sigma-Aldrich) and dispase
(Sigma-Aldrich) (50:50), after which the epidermis was peeled off
and discarded. The dermis was minced and incubated for 1 hour at
37C in 0.25% collagenase in FAD basal medium (Gibco, Waltham,
MA). The resulting cell suspension was filtered through a 70-mm cell
strainer (SLS, Nottingham, England) and centrifuged at 1,800 r.p.m.
for 4 minutes at 25C. The supernatant was removed, and the pellet
was washed three times with PBS. Finally, the pellet was resus-
pended in Amniomax medium (Gibco), and cells were used for flow
cytometry and RNA extraction.
Isolation of adult human fibroblasts
Human adult surgical waste skin was cut into 5-mmediameter
pieces and incubated with dispase for 1 hour at 37C. The epidermis
was peeled off and discarded, and the dermis was digested overnight
at 37C using enzymes from a whole-skin dissociation kit (Miltenyi,
Bergisch-Gladbach, Germany). The resulting cell suspension was
filtered through a 70-mm cell strainer and centrifuged at 1,500 r.p.m.
for 10 minutes at 4C. The supernatant was removed, and the pellet
was washed once with PBS at 1,500 r.p.m. for 4 minutes at 4C. The
pellet was resuspended in PBS plus 1% fetal bovine serum for flow
cytometry or lysis buffer containing 2-mercaptoethanol (Qiagen,
Hilden, Germany) for RNA extraction.Journal of Investigative Dermatology (2018), Volume 138Cell culture
Human adult dermal fibroblasts were cultured in DMEM plus 10%
(volume/volume) fetal bovine serum, 2 mmol/L L-glutamine, and 100
U/ml penicillin, 100 mg/ml streptomycin (Gibco), or Amniomax
C100 medium with Amniomax C100 supplement (Gibco). Culture
flasks were incubated at 37C in a humidified atmosphere with 5%
CO2 and passaged every 3e5 days, when 80% confluent. Cells were
used between passages 1 and 6 for all studies. Stock cultures of
primary normal human keratinocytes (strain km) were obtained from
surgically discarded foreskin and grown on 3T3-J2 feeder cells.
Normal human keratinocytes were used for DED experiments be-
tween passages 2 and 5. 3T3-J2 fibroblasts were originally obtained
from James Rheinwald (Department of Dermatology, Skin Disease
Research Center, Brigham and Women’s Hospital, Boston, MA), not
authenticated. All cell stocks were routinely tested for mycoplasma
contamination, and results were negative. Normal human kerati-
nocytes were cultured in complete FAD medium, containing one
part Ham’s F12, three parts DMEM, 104mol/L adenine, 10% (vol-
ume/volume) fetal bovine serum, 0.5 mg/ml hydrocortisone, 5mg/ml
insulin, 1010mol/L cholera toxin, and 10 ng/ml EGF, on mitotically
inactivated 3T3-J2 cells as described previously (Jones and Watt,
1993; Rheinwald and Green, 1975). For IFN-gestimulation assays,
human dermal fibroblasts were stimulated with 1,000 U/ml IFN-g
(Sigma-Aldrich) for 72 hours in growth medium before harvesting for
analysis by flow cytometry.
DED was prepared as described previously (Rikimaru et al.,
1997). Briefly, adult human skin was divided into 1e2 cm2
squares and heated at 52C for 20 minutes, and the epidermis was
separated from the dermis with forceps. The dermis was depleted of
cells by at least 10 freeze-thaw cycles and irradiated once with 60
Gy. Before fibroblasts were seeded onto DEDs, the tissue was placed
into six-well hanging cell culture inserts (Millipore, Billerica, MA)
and equilibrated with DMEM. Fibroblasts, 5  105 cells/DED, were
injected into the DED using U-100 insulin syringes (BD, Franklin
Lakes, NJ) from the epidermis surface and then incubated for 72
hours completely submerged in DMEM. Medium was changed to
FAD medium, DEDs were placed at the air-liquid interface and 1 
106 keratinocytes were seeded on top of each DED. DEDs were
maintained in culture with FAD medium at the air-liquid interface
for 3 weeks with medium changes every 48 hours.
Flow cytometry
Disaggregated dermal cells were labeled with antibodies in PBS plus
1% fetal bovine serum for 45 minutes at 4C. DAPI was used to
exclude dead cells. Fluorescence minus one controls were used
during the experimental set up. After incubation, cells were centri-
fuged at 1,500 r.p.m. for 4 minutes at 4C and washed three times in
PBS plus 1% fetal bovine serum. Pellets were resuspended in PBS
plus 1% FCS and filtered through a 50-mm cell strainer. Data
acquisition was performed using the BD FACSCanto II fluidics and
LSRFortessa cell analyzer systems. Cell sorting was performed on the
BD FACSAria II and BD FACSAria III Fusion cell sorters. For gate
setting and compensation, unlabeled, single-labeled cells and
compensation beads (BD) were used as controls. Data analysis was
performed using FlowJo software, version 10 (Tree Star, Ashland,
OR).
Quantitative real-time reverse transcriptaseePCR
Total RNA was isolated using the Qiagen RNeasy mini kit, and
cDNA was synthesized using the QuantiTect Reverse Transcription
kit (Qiagen) or Superscript III First-Strand Synthesis (Thermo Fisher).
C Philippeos et al.
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action by adding 1 ml of RNAse H per 30 ml reaction for 20 minutes
in PCR block at 37C.
Quantitative real-time reverse transcriptaseePCR reactions were
performed onCFX384Real-Time System (Bio-Rad,Hercules, CA) using
the standard protocols for TaqMan Fast Universal PCRMaster Mix with
TaqMan probes, or using SYBR-Green Master Mix (Life Technologies)
using qPCR primers (published or designedwith Primer3). Values were
normalized to GAPDH, 18S, or TBP expression levels using the DCT
method. Each reaction was completed with at least biological tripli-
cates unless otherwise stated. The following TaqMan probeswere used:
CD36 Mm01135198_m1, AKAP12 Mm00513511_m1, CHODL
Mm00507273_m1, mouse GAPDH endogenous control (4352339E),
CD39 Mm00515447_m1, Akr1c18 Mm00506289_m1., IL6
Mm00446190_m1, and NRK Mm00479081_m1.
Affymetrix microarrays
cDNA was fragmentated and labeled with the Affymetrix GeneChip
Labeling Kit. The labeled DNA target and fragmented cDNA were
hybridized on Mouse Gene 2.0 ST Arrays (Affymetrix). The micro-
arrays were scanned on a GeneChip scanner 3000 (Affymetrix).
The data are deposited in Gene Expression Omnibus (GSE104225).
RNA sequencing
Spatial RNA sequencing was performed using fresh human skin
samples (from three separate individuals). Skin samples were incu-
bated with Dispase II (Stemcell Technologies, Vancouver Canada)
for 1 hour at 37C permitting separation of the epidermis. The dermis
was separated into papillary (upper 100 mm) and reticular (200e500
mm) dermis by microdissection under a dissecting microscope.
Separated papillary and reticular dermis samples were subsequently
transferred to lysis buffer containing 2-mercaptoethanol (PureLink
RNA micro scale kit, Invitrogen) and homogenized for 2 minutes
using a mechanical homogenizer (Polytron, Kinematica, Luzern,
Switzerland). Subsequent RNA extraction was performed using the
PureLink micro kit according to the manufacturer’s instructions.
Library preparation was performed according to the SmartSeq2
protocol (Picelli et al., 2014).
For single-cell RNA sequencing, single cells were isolated by flow
cytometry (as described) from the abdominal skin of a single donor.
Cells were sorted into individual wells of a 96-well plate containing
2 ml lysis buffer (0.2% (volume/volume) Triton X-100 and 2 U/ml
recombinant RNase inhibitor (Clontech, Mountain View, CA). Li-
brary preparation was performed with SmartSeq2, followed by the
Nextera XT protocol (Illumina, San Diego, CA). Sequencing was
performed on the Illumina Hiseq2000 or Hiseq 25000 with TruSeq
SBS v3 chemistry.
Reads were mapped with Tophat2 (Kim et al., 2013). Gene-
specific expression was quantified using featureCounts (Liao et al.,
2014). The data are deposited in Gene Expression Omnibus
(GSE109822). Cells for which less than 200,000 total reads were
mapped were excluded from further analysis. Reads were normal-
ized on a per-cell basis to give mapped reads per million. Statistical
analysis and visualization of single-cell sequencing data were per-
formed using the Seurat package for R according to the recom-
mended protocol (Satija Lab, New York, NY).
Graphing and statistical analysis
Graphs were generated using Excel (Microsoft, Redmond, WA) and
GraphPad (La Jolla, CA) Prism 6 software. Data are mean standard
error of the mean. One-way analysis of variance parametric test withBonferroni posttest or Student tests were performed for experiments,
with P< 0.05 considered significant.
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